How not to neglect the care of elderly breast cancer patients?

[1]  A. Melville,et al.  Guidance on cancer services : improving outcomes in breast cancer - manual update. , 2009 .

[2]  H. Bartelink,et al.  Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. , 2007, The Lancet. Oncology.

[3]  M. Reed,et al.  Surgery, with or without tamoxifen, vs tamoxifen alone for older women with operable breast cancer: Cochrane review , 2007, British Journal of Cancer.

[4]  E. Ford,et al.  The impact of cognitive functioning on mortality and the development of functional disability in older adults with diabetes: the second longitudinal study on aging , 2006, BMC geriatrics.

[5]  R. Collins,et al.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[6]  M. Dowsett,et al.  Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. , 2005, The New England journal of medicine.

[7]  Greg Yothers,et al.  Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. , 2005, The New England journal of medicine.

[8]  Y Wang,et al.  Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[9]  J. Cuzick,et al.  Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer , 2005, The Lancet.

[10]  R. Audisio.  The surgical risk of elderly patients with cancer. , 2004, Surgical oncology.

[11]  E. Carey,et al.  Development and validation of a functional morbidity index to predict mortality in community-dwelling elders , 2004, Journal of General Internal Medicine.

[12]  A. Luini,et al.  Breast carcinoma in elderly women , 2004, Cancer.

[13]  M. Baum,et al.  Late follow‐up of a randomized trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer , 2004, The British journal of surgery.

[14]  M. Reed,et al.  Stage and treatment variation with age in postmenopausal women with breast cancer: compliance with guidelines , 2004, British Journal of Cancer.

[15]  J. Cuzick,et al.  Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early‐stage breast cancer , 2003, Cancer.

[16]  James N Ingle,et al.  Aromatase inhibitors versus tamoxifen for management of postmenopausal breast cancer in the advanced disease and neoadjuvant settings , 2003, The Journal of Steroid Biochemistry and Molecular Biology.

[17]  C. Hudis,et al.  Factors influencing treatment patterns of breast cancer patients age 75 and older. , 2003, Critical reviews in oncology/hematology.

[18]  L. Tabár,et al.  Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening , 2003, The Lancet.

[19]  M. Reed,et al.  The need for targeted research into breast cancer in the elderly , 2003, The British journal of surgery.

[20]  S. Milani,et al.  Tamoxifen alone versus adjuvant tamoxifen for operable breast cancer of the elderly: long-term results of the phase III randomized controlled multicenter GRETA trial. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[21]  I. Fentiman,et al.  Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomy. , 2003, European journal of cancer.

[22]  Robert F Schoeni,et al.  Recent trends in disability and functioning among older adults in the United States: a systematic review. , 2002, JAMA.

[23]  S. Cummings,et al.  Epidemiology and outcomes of osteoporotic fractures , 2002, The Lancet.

[24]  H. Hendrie,et al.  Cognitive Impairment and Mortality in Older Primary Care Patients , 2001, Journal of the American Geriatrics Society.

[25]  R Yancik,et al.  Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. , 2001, JAMA.

[26]  S. Edge,et al.  Patterns of breast carcinoma treatment in older women , 2000, Cancer.

[27]  R. Elledge,et al.  Tumor characteristics and clinical outcome of elderly women with breast cancer. , 2000, Journal of the National Cancer Institute.

[28]  H O Dickinson,et al.  Cancer trends in England and Wales , 2000, BMJ : British Medical Journal.

[29]  M. Callam,et al.  Age‐related variation in the treatment and outcomes of patients with breast carcinoma , 2000, Cancer.

[30]  G. Mulley,et al.  Cancer in old age—is it inadequately investigated and treated? , 1999, BMJ.

[31]  J. Fulton,et al.  Is surgical management compromised in elderly patients with breast cancer? , 1997, Annals of surgery.

[32]  W. Scott,et al.  Functional health status as a predictor of mortality in men and women over 65. , 1997, Journal of clinical epidemiology.

[33]  U. Wolters,et al.  ASA classification and perioperative variables as predictors of postoperative outcome. , 1996, British journal of anaesthesia.

[34]  R. Coombes,et al.  Prospective randomized trial of tamoxifen vs surgery in elderly patients with breast cancer. , 1994, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[35]  W. Satariano,et al.  The Effect of Comorbidity on 3-Year Survival of Women with Primary Breast Cancer , 1994, Annals of Internal Medicine.

[36]  T. Junginger,et al.  Predictive value of ASA classification for the assessment of the perioperative risk. , 1993, International surgery.

[37]  I. Ellis,et al.  Mastectomy or tamoxifen as initial therapy for operable breast cancer in elderly patients: 5-year follow-up. , 1992, European journal of cancer.

[38]  E. Wagner,et al.  Preventing frail health. , 1992, Clinics in geriatric medicine.

[39]  V. Sondak,et al.  Age-related differences in breast cancer treatment , 2006, Annals of Surgical Oncology.

[40]  Laurence Z. Rubenstein,et al.  Geriatric assessment technology : the state of the art , 1995 .

[41]  Joseph J. Gallo,et al.  Handbook of geriatric assessment , 1988 .

[42]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[43]  A. Adelstein.  Studies on medical and population subjects. , 1976 .